Literature DB >> 26193637

Increased H3K9me3 drives dedifferentiated phenotype via KLF6 repression in liposarcoma.

Emily Z Keung, Kadir C Akdemir, Ghadah A Al Sannaa, Jeannine Garnett, Dina Lev, Keila E Torres, Alexander J Lazar, Kunal Rai, Lynda Chin.   

Abstract

Liposarcoma (LPS) can be divided into 4 different subtypes, of which well-differentiated LPS (WDLPS) and dedifferentiated LPS (DDLPS) are the most common. WDLPS is typically low grade, whereas DDLPS is high grade, aggressive, and carries a worse prognosis. WDLPS and DDLPS frequently co-occur in patients. However, it is not clear whether DDLPS arises independently from WDLPS, or whether epigenomic alterations underly the histopathological differences of these subtypes. Here, we profiled 9 epigenetic marks in tumor samples from 151 patients with LPS and showed elevated trimethylation of histone H3 at Lys9 (H3K9me3) levels in DDLPS tumors. Integrated ChIP-seq and gene expression analyses of patient-derived cell lines revealed that H3K9me3 mediates differential regulation of genes involved in cellular differentiation and migration. Among these, Kruppel-like factor 6 (KLF6) was reduced in DDLPS, with increased H3K9me3 at associated regulatory regions. Pharmacologic inhibition of H3K9me3 with chaetocin decreased DDLPS proliferation and increased expression of the adipogenesis-associated factors PPARγ, CEBPα, and CEBPβ, suggesting that increased H3K9me3 may mediate DDLPS-associated aggressiveness and dedifferentiation properties. KLF6 overexpression partially phenocopied chaetocin treatment in DDLPS cells and induced phenotypic changes that were consistent with adipocytic differentiation, suggesting that the effects of increased H3K9me3 may be mediated through KLF6. In conclusion, we provide evidence of an epigenetic basis for the transition between WDLPS and DDLPS.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26193637      PMCID: PMC4563740          DOI: 10.1172/JCI77976

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  49 in total

1.  Super-enhancers in the control of cell identity and disease.

Authors:  Denes Hnisz; Brian J Abraham; Tong Ihn Lee; Ashley Lau; Violaine Saint-André; Alla A Sigova; Heather A Hoke; Richard A Young
Journal:  Cell       Date:  2013-10-10       Impact factor: 41.582

2.  Transcription factor cooperativity in early adipogenic hotspots and super-enhancers.

Authors:  Rasmus Siersbæk; Atefeh Rabiee; Ronni Nielsen; Simone Sidoli; Sofie Traynor; Anne Loft; Lars La Cour Poulsen; Adelina Rogowska-Wrzesinska; Ole N Jensen; Susanne Mandrup
Journal:  Cell Rep       Date:  2014-05-22       Impact factor: 9.423

Review 3.  Coordinated chromatin control: structural and functional linkage of DNA and histone methylation.

Authors:  Xiaodong Cheng; Robert M Blumenthal
Journal:  Biochemistry       Date:  2010-04-13       Impact factor: 3.162

4.  Identification of a specific inhibitor of the histone methyltransferase SU(VAR)3-9.

Authors:  Dorothea Greiner; Tiziana Bonaldi; Ragnhild Eskeland; Ernst Roemer; Axel Imhof
Journal:  Nat Chem Biol       Date:  2005-07-17       Impact factor: 15.040

5.  MiR-155 is a liposarcoma oncogene that targets casein kinase-1α and enhances β-catenin signaling.

Authors:  Pingyu Zhang; Katelynn Bill; Juehui Liu; Eric Young; Tingsheng Peng; Svetlana Bolshakov; Aviad Hoffman; Yechun Song; Elizabeth G Demicco; Dolores Lopez Terrada; Chad J Creighton; Matthew L Anderson; Alexander J Lazar; George G Calin; Raphael E Pollock; Dina Lev
Journal:  Cancer Res       Date:  2012-02-20       Impact factor: 12.701

6.  Frequent alterations and epigenetic silencing of differentiation pathway genes in structurally rearranged liposarcomas.

Authors:  Barry S Taylor; Penelope L DeCarolis; Christina V Angeles; Fabienne Brenet; Nikolaus Schultz; Cristina R Antonescu; Joseph M Scandura; Chris Sander; Agnes J Viale; Nicholas D Socci; Samuel Singer
Journal:  Cancer Discov       Date:  2011-12       Impact factor: 39.397

7.  Cyclin-dependent kinase inhibition by the KLF6 tumor suppressor protein through interaction with cyclin D1.

Authors:  Sharon Benzeno; Goutham Narla; Jorge Allina; George Z Cheng; Helen L Reeves; Michaela S Banck; Joseph A Odin; J Alan Diehl; Doris Germain; Scott L Friedman
Journal:  Cancer Res       Date:  2004-06-01       Impact factor: 12.701

8.  KLF6-SV1 is a novel antiapoptotic protein that targets the BH3-only protein NOXA for degradation and whose inhibition extends survival in an ovarian cancer model.

Authors:  Analisa Difeo; Fei Huang; Jaya Sangodkar; Esteban A Terzo; Devin Leake; Goutham Narla; John A Martignetti
Journal:  Cancer Res       Date:  2009-05-12       Impact factor: 12.701

9.  A high-throughput chromatin immunoprecipitation approach reveals principles of dynamic gene regulation in mammals.

Authors:  Manuel Garber; Nir Yosef; Alon Goren; Raktima Raychowdhury; Anne Thielke; Mitchell Guttman; James Robinson; Brian Minie; Nicolas Chevrier; Zohar Itzhaki; Ronnie Blecher-Gonen; Chamutal Bornstein; Daniela Amann-Zalcenstein; Assaf Weiner; Dennis Friedrich; James Meldrim; Oren Ram; Christine Cheng; Andreas Gnirke; Sheila Fisher; Nir Friedman; Bang Wong; Bradley E Bernstein; Chad Nusbaum; Nir Hacohen; Aviv Regev; Ido Amit
Journal:  Mol Cell       Date:  2012-08-30       Impact factor: 17.970

10.  Integrative DNA methylation and gene expression analysis in high-grade soft tissue sarcomas.

Authors:  Marcus Renner; Thomas Wolf; Hannah Meyer; Wolfgang Hartmann; Roland Penzel; Alexis Ulrich; Burkhard Lehner; Volker Hovestadt; Esteban Czwan; Gerlinde Egerer; Thomas Schmitt; Ingo Alldinger; Eva Kristin Renker; Volker Ehemann; Roland Eils; Eva Wardelmann; Reinhard Büttner; Peter Lichter; Benedikt Brors; Peter Schirmacher; Gunhild Mechtersheimer
Journal:  Genome Biol       Date:  2013-12-17       Impact factor: 13.583

View more
  15 in total

1.  H3K9me3, H3K36me3, and H4K20me3 Expression Correlates with Patient Outcome in Esophageal Squamous Cell Carcinoma as Epigenetic Markers.

Authors:  Menghan Zhou; Yiping Li; Shaofeng Lin; Yanping Chen; Yanyan Qian; Zhujiang Zhao; Hong Fan
Journal:  Dig Dis Sci       Date:  2019-02-20       Impact factor: 3.199

2.  Experimental models of undifferentiated pleomorphic sarcoma and malignant peripheral nerve sheath tumor.

Authors:  Angela D Bhalla; Sharon M Landers; Anand K Singh; Jace P Landry; Michelle G Yeagley; Gabryella S B Myerson; Cristian B Delgado-Baez; Stephanie Dunnand; Theresa Nguyen; Xiaoyan Ma; Svetlana Bolshakov; Brian A Menegaz; Salah-Eddine Lamhamedi-Cherradi; Xizeng Mao; Xingzhi Song; Alexander J Lazar; Ian E McCutcheon; John M Slopis; Joseph A Ludwig; Dina C Lev; Kunal Rai; Keila E Torres
Journal:  Lab Invest       Date:  2022-02-28       Impact factor: 5.662

3.  Mutant p53 perturbs DNA replication checkpoint control through TopBP1 and Treslin.

Authors:  Kang Liu; Fang-Tsyr Lin; Joshua D Graves; Yu-Ju Lee; Weei-Chin Lin
Journal:  Proc Natl Acad Sci U S A       Date:  2017-04-24       Impact factor: 11.205

4.  Methylation Patterns of Lys9 and Lys27 on Histone H3 Correlate with Patient Outcome in Gastric Cancer.

Authors:  Yiping Li; Didi Guo; Rui Sun; Ping Chen; Qi Qian; Hong Fan
Journal:  Dig Dis Sci       Date:  2018-10-22       Impact factor: 3.199

5.  H3K9me3-mediated repression of KLF6: Discovering a novel tumor suppressor in liposarcoma using a systematic epigenomic approach.

Authors:  Emily Z Keung; Kunal Rai
Journal:  Mol Cell Oncol       Date:  2015-10-29

6.  Over-methylation of Histone H3 Lysines Is a Common Molecular Change Among the Three Major Types of Soft-tissue Sarcoma in Patient-derived Xenograft (PDX) Mouse Models.

Authors:  Yusuke Aoki; Jun Yamamoto; Yasunori Tome; Kazuyuki Hamada; Noriyuki Masaki; Sachiko Inubushi; Yoshihiko Tashiro; Michael Bouvet; Itaru Endo; Kotaro Nishida; Robert M Hoffman
Journal:  Cancer Genomics Proteomics       Date:  2021 Nov-Dec       Impact factor: 4.069

7.  KLF6 depletion promotes NF-κB signaling in glioblastoma.

Authors:  A P Masilamani; R Ferrarese; E Kling; N K Thudi; H Kim; D M Scholtens; F Dai; M Hadler; T Unterkircher; L Platania; A Weyerbrock; M Prinz; G Y Gillespie; G R Harsh; M Bredel; M S Carro
Journal:  Oncogene       Date:  2017-02-06       Impact factor: 9.867

8.  Notch activation drives adipocyte dedifferentiation and tumorigenic transformation in mice.

Authors:  Pengpeng Bi; Feng Yue; Anju Karki; Beatriz Castro; Sara E Wirbisky; Chao Wang; Abigail Durkes; Bennett D Elzey; Ourania M Andrisani; Christopher A Bidwell; Jennifer L Freeman; Stephen F Konieczny; Shihuan Kuang
Journal:  J Exp Med       Date:  2016-08-29       Impact factor: 14.307

9.  G protein pathway suppressor 2 (GPS2) acts as a tumor suppressor in liposarcoma.

Authors:  Xiao-Dong Huang; Feng-Jun Xiao; Shao-Xia Wang; Rong-Hua Yin; Can-Rong Lu; Qing-Fang Li; Na Liu; Ying Zhang; Li-Sheng Wang; Pei-Yu Li
Journal:  Tumour Biol       Date:  2016-07-26

10.  Genomic profiling of dedifferentiated liposarcoma compared to matched well-differentiated liposarcoma reveals higher genomic complexity and a common origin.

Authors:  Hannah C Beird; Chia-Chin Wu; Davis R Ingram; Wei-Lien Wang; Asrar Alimohamed; Curtis Gumbs; Latasha Little; Xingzhi Song; Barry W Feig; Christina L Roland; Jianhua Zhang; Robert S Benjamin; Patrick Hwu; Alexander J Lazar; P Andrew Futreal; Neeta Somaiah
Journal:  Cold Spring Harb Mol Case Stud       Date:  2018-04-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.